LumiThera Receives Grant of $250K
Clark Tedford of LumiThera has received a $250,000 grant to treat macular degeneration from the Life Sciences Discovery Fund (LSDF).
Part of LSDF’s $1.25 million Proof of Concept program, the grants are meant to accelerate the maturation of promising health-related technologies into commercial products. LumiThera’s project will focus on building a device that may delay the progression of dry age-related macular degeneration through the use of low-level laser therapy.
“LSDF created the Proof of Concept granting program to nurture the vitality and competitiveness of Washington’s life sciences innovation community and help convert its ‘intellectual capital’ into tangible products,” said John DesRosier, LSDF executive director.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024